{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:45:53Z","timestamp":1793450753369,"version":"4.5.0"},"reference-count":146,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jvs.2025.04.041","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T23:58:15Z","timestamp":1746057495000},"page":"303-326.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Society for Vascular Surgery Clinical Practice Guideline on the management of intermittent claudication: Focused update"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9119-192X","authenticated-orcid":false,"given":"Michael S.","family":"Conte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Aulivola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal R.","family":"Barshes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Bertges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Corriere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Hassan","family":"Murad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy B.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"William P.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica P.","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3 Suppl","key":"10.1016\/j.jvs.2025.04.041_bib1","doi-asserted-by":"crossref","first-page":"2s","DOI":"10.1016\/j.jvs.2014.12.009","article-title":"Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication","volume":"61","author":"Conte","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib2","doi-asserted-by":"crossref","first-page":"e1313","DOI":"10.1161\/CIR.0000000000001251","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"149","author":"Gornik","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2025.04.041_bib3","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1161\/CIR.0000000000001285","article-title":"2024 AHA\/ACC\/ACS\/ASNC\/HRS\/SCA\/SCCT\/SCMR\/SVM guideline for perioperative cardiovascular management for noncardiac surgery: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"150","author":"Thompson","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2025.04.041_bib4","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","article-title":"2024 ESC Guidelines for the management of peripheral arterial and aortic diseases","volume":"45","author":"Mazzolai","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2025.04.041_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jama.2014.5559","article-title":"How to read a systematic review and meta-analysis and apply the results to patient care: users' guides to the medical literature","volume":"312","author":"Murad","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2025.04.041_bib7","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jclinepi.2011.06.004","article-title":"GRADE guidelines: 9. Rating up the quality of evidence","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jvs.2025.04.041_bib8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.mayocp.2017.01.001","article-title":"Clinical practice guidelines: a primer on development and dissemination","volume":"92","author":"Murad","year":"2017","journal-title":"Mayo Clinic Proc"},{"issue":"5 Suppl","key":"10.1016\/j.jvs.2025.04.041_bib9","doi-asserted-by":"crossref","first-page":"26s","DOI":"10.1016\/j.jvs.2008.08.045","article-title":"Methodology for clinical practice guidelines for the management of arteriovenous access","volume":"48","author":"Murad","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib10","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jvs.2011.01.036","article-title":"Guideline methodology of the Society for Vascular Surgery including the experience with the GRADE framework","volume":"53","author":"Murad","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jvs.2024.12.135","article-title":"A systematic review supporting the Society for Vascular Surgery guideline update on the management of intermittent claudication","volume":"82","author":"Saadi","year":"2025","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib12","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.jacc.2018.08.002","article-title":"Pathology of peripheral artery disease in patients with critical limb ischemia","volume":"72","author":"Narula","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"8 Pt 1","key":"10.1016\/j.jvs.2025.04.041_bib13","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.jcmg.2018.08.039","article-title":"Histopathologic characterization of peripheral arteries in subjects with abundant risk factors: correlating imaging with pathology","volume":"12","author":"Torii","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jvs.2025.04.041_bib14","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1161\/CIRCULATIONAHA.112.000679","article-title":"Vorapaxar in patients with peripheral artery disease: results from TRA2{degrees}P-TIMI 50","volume":"127","author":"Bonaca","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2025.04.041_bib15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Anand","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2025.04.041_bib16","first-page":"1027","article-title":"Rationale, design and baseline characteristics of participants in the cardiovascular outcomes for people using anticoagulation strategies (COMPASS) trial","volume":"33","author":"Bosch","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jvs.2025.04.041_bib17","first-page":"21","article-title":"Rivaroxaban and aspirin in patients with symptomatic lower extremity peripheral artery disease: a subanalysis of the COMPASS randomized clinical trial","volume":"6","author":"Kaplovitch","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jvs.2025.04.041_bib18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ahj.2023.01.008","article-title":"Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: the COMPASS trial","volume":"258","author":"Branch","year":"2023","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvs.2025.04.041_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.5239","article-title":"Polyvascular disease and risk of major adverse cardiovascular events in peripheral artery disease: a secondary analysis of the EUCLID trial","volume":"1","author":"Gutierrez","year":"2018","journal-title":"JAMA Netw open"},{"key":"10.1016\/j.jvs.2025.04.041_bib20","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"The New Engl J Med"},{"key":"10.1016\/j.jvs.2025.04.041_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ahj.2018.01.011","article-title":"Rationale and design for the vascular outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)","volume":"199","author":"Capell","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvs.2025.04.041_bib22","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/CIRCULATIONAHA.121.055146","article-title":"Reduction in acute limb ischemia with rivaroxaban versus placebo in peripheral artery disease after lower extremity revascularization: insights from VOYAGER PAD","volume":"144","author":"Hess","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2025.04.041_bib23","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jvs.2022.11.062","article-title":"Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits","volume":"77","author":"Govsyeyev","year":"2023","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib24","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1161\/CIRCULATIONAHA.120.050465","article-title":"Rivaroxaban and aspirin in peripheral artery disease lower extremity revascularization: impact of concomitant clopidogrel on efficacy and safety","volume":"142","author":"Hiatt","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2025.04.041_bib25","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jacc.2021.06.021","article-title":"Rivaroxaban in patients with recent peripheral artery revascularization and renal impairment: the VOYAGER PAD trial","volume":"78","author":"Hsia","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2025.04.041_bib26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejvs.2021.05.028","article-title":"Editor's choice - external applicability of the COMPASS and VOYAGER-PAD trials on patients with symptomatic lower extremity artery disease in France: the COPART registry","volume":"62","author":"Lap\u00e9bie","year":"2021","journal-title":"Eur J Vasc endovascular Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.23736\/S0392-9590.21.04816-1","article-title":"Prevalence of VOYAGER PAD trial exclusion criteria in unselected patients undergoing lower limb revascularization","volume":"41","author":"Moll","year":"2022","journal-title":"Int Angiol"},{"key":"10.1016\/j.jvs.2025.04.041_bib28","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.jacc.2007.07.058","article-title":"Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes","volume":"50","author":"Storey","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2025.04.041_bib29","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2025.04.041_bib30","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2025.04.041_bib31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1611688","article-title":"Ticagrelor versus clopidogrel in symptomatic peripheral artery disease","volume":"376","author":"Hiatt","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2025.04.041_bib32","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijcard.2020.01.024","article-title":"Ticagrelor versus clopidogrel in patients undergoing implantation of paclitaxel-eluting stent in the femoropopliteal district: a randomized pilot study using frequency-domain optical coherence tomography","volume":"304","author":"Ducci","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jvs.2025.04.041_bib33","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s40265-022-01756-6","article-title":"Antithrombotic therapy for symptomatic peripheral arterial disease: a systematic review and network meta-analysis","volume":"82","author":"Willems","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.jvs.2025.04.041_bib34","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3390\/ph15050596","article-title":"Mono or dual antiplatelet therapy for treating patients with peripheral artery disease after lower extremity revascularization: a systematic review and meta-analysis","volume":"15","author":"Tsai","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jvs.2025.04.041_bib35","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jvs.2012.04.046","article-title":"Supervised walking therapy in patients with intermittent claudication","volume":"56","author":"Fakhry","year":"2012","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib36","first-page":"e726","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2025.04.041_bib38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2013.7231","article-title":"Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial","volume":"310","author":"McDermott","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2025.04.041_bib39","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.cct.2012.08.001","article-title":"The group oriented arterial leg study (GOALS) to improve walking performance in patients with peripheral arterial disease","volume":"33","author":"McDermott","year":"2012","journal-title":"Contemp Clin trials"},{"key":"10.1016\/j.jvs.2025.04.041_bib40","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000711","article-title":"Home-based walking exercise in peripheral artery disease: 12-month follow-up of the GOALS randomized trial","volume":"3","author":"McDermott","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jvs.2025.04.041_bib41","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/jama.2018.3275","article-title":"Effect of a home-based exercise intervention of wearable technology and telephone coaching on walking performance in peripheral artery disease: the HONOR randomized clinical trial","volume":"319","author":"McDermott","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2025.04.041_bib42","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.jvs.2022.06.087","article-title":"Use of an app-based exercise therapy program including cognitive-behavioral techniques for the management of intermittent claudication","volume":"76","author":"Aalami","year":"2022","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib43","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.avsg.2016.02.009","article-title":"A systematic review of the uptake and adherence rates to supervised exercise programs in patients with intermittent claudication","volume":"34","author":"Harwood","year":"2016","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib44","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.jvs.2017.05.111","article-title":"Exercise training for intermittent claudication","volume":"66","author":"McDermott","year":"2017","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/CIRCULATIONAHA.114.007002","article-title":"Six-minute walk is a better outcome measure than treadmill walking tests in therapeutic trials of patients with peripheral artery disease","volume":"130","author":"McDermott","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2025.04.041_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001107","article-title":"Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial","volume":"3","author":"Gardner","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jvs.2025.04.041_bib47","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1161\/CIRCULATIONAHA.116.023691","article-title":"Home-based exercise: a therapeutic option for peripheral artery disease","volume":"134","author":"McDermott","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2025.04.041_bib48","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/nur.21992","article-title":"Attention control group activities and perceived benefit in a trial of a behavioral intervention for older adults","volume":"42","author":"LaFave","year":"2019","journal-title":"Res Nurs Health"},{"key":"10.1016\/j.jvs.2025.04.041_bib49","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2021.2536","article-title":"Effect of low-intensity vs high-intensity home-based walking exercise on walk distance in patients with peripheral artery disease: the LITE randomized clinical trial","volume":"325","author":"McDermott","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2025.04.041_bib50","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.025063","article-title":"Effects of walking exercise at a pace with versus without ischemic leg symptoms on functional performance measures in people with lower extremity peripheral artery disease: the LITE randomized clinical trial","volume":"11","author":"Hammond","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jvs.2025.04.041_bib51","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1358863X211060388","article-title":"Safety of home-based exercise for people with intermittent claudication: a systematic review","volume":"27","author":"Waddell","year":"2022","journal-title":"Vasc Med"},{"key":"10.1016\/j.jvs.2025.04.041_bib52","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/jep.12629","article-title":"Minimal clinically important difference for change in 6-minute walk test distance of adults with pathology: a systematic review","volume":"23","author":"Bohannon","year":"2017","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/j.jvs.2025.04.041_bib53","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jvs.2022.09.002","article-title":"Characterizing patient-reported claudication treatment goals to support patient-centered treatment selection and measurement strategies","volume":"77","author":"Powell","year":"2023","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib54","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/jama.2015.14851","article-title":"Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial","volume":"314","author":"Fakhry","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2025.04.041_bib55","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/bjs.10198","article-title":"Two-year results from a randomized clinical trial of revascularization in patients with intermittent claudication","volume":"103","author":"Nordanstig","year":"2016","journal-title":"Br J Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib56","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/bjs.10324","article-title":"Long-term outcomes of a randomized clinical trial of supervised exercise, percutaneous transluminal angioplasty or combined treatment for patients with intermittent claudication due to femoropopliteal disease","volume":"104","author":"Mazari","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib57","article-title":"Absence of long-term benefit of revascularization in patients with intermittent claudication: five-year results from the IRONIC randomized controlled trial","volume":"13","author":"Djerf","year":"2020","journal-title":"Circ Cardiovasc interv"},{"key":"10.1016\/j.jvs.2025.04.041_bib58","doi-asserted-by":"crossref","first-page":"e1035","DOI":"10.1097\/SLA.0000000000004712","article-title":"Long-term follow-up of a randomized clinical trial comparing endovascular revascularization plus supervised exercise with supervised exercise only for intermittent claudication","volume":"276","author":"Klaphake","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib59","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.121.010703","article-title":"Endovascular revascularization plus supervised exercise versus supervised exercise only for intermittent claudication: a cost-effectiveness analysis","volume":"14","author":"Fakhry","year":"2021","journal-title":"Circ Cardiovasc interv"},{"key":"10.1016\/j.jvs.2025.04.041_bib60","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019672","article-title":"Network meta-analysis comparing the outcomes of treatments for intermittent claudication tested in randomized controlled trials","volume":"10","author":"Thanigaimani","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jvs.2025.04.041_bib61","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2025.04.041_bib63","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1161\/CIRCULATIONAHA.106.174526","volume":"113","author":"Hirsch","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2025.04.041_bib64","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ejvs.2015.10.022","article-title":"The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease","volume":"51","author":"Sigvant","year":"2016","journal-title":"Eur J Vasc Endovascular Surg"},{"issue":"Suppl S","key":"10.1016\/j.jvs.2025.04.041_bib65","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib66","first-page":"123","article-title":"The natural history of claudication: risk to life and limb","volume":"12","author":"Dormandy","year":"1999","journal-title":"Semin Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib67","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/bmj.2.5199.633","article-title":"The fate of the claudicator","volume":"2","author":"Singer","year":"1960","journal-title":"Br Med J"},{"key":"10.1016\/j.jvs.2025.04.041_bib68","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.avsg.2020.10.004","article-title":"Multiple reinterventions for claudication are associated with progression to chronic limb-threatening ischemia","volume":"72","author":"Kim","year":"2021","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib69","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jvs.2011.03.281","article-title":"Trends in the national outcomes and costs for claudication and limb threatening ischemia: angioplasty vs bypass graft","volume":"54","author":"Sachs","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib70","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.avsg.2021.10.068","article-title":"Rates of intervention for claudication versus chronic limb-threatening ischemia in Canada and United States","volume":"82","author":"Li","year":"2022","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib71","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jacc.2014.12.048","article-title":"Trends in settings for peripheral vascular intervention and the effect of changes in the outpatient prospective payment system","volume":"65","author":"Jones","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2025.04.041_bib72","doi-asserted-by":"crossref","first-page":"E365","DOI":"10.25270\/jic\/20.00594","article-title":"Procedural and 3-year outcomes of peripheral vascular interventions performed in office-based labs: LIBERTY 360 sub-analysis","volume":"33","author":"Giannopoulos","year":"2021","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.jvs.2025.04.041_bib73","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jvs.2019.05.005","article-title":"Overuse of early peripheral vascular interventions for claudication","volume":"71","author":"Hicks","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib74","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.avsg.2017.04.046","article-title":"Smoking Habits of patients undergoing treatment for intermittent claudication in the vascular quality initiative","volume":"44","author":"Gabel","year":"2017","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib75","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jvs.2022.10.025","article-title":"Early peripheral vascular interventions for claudication are associated with higher rates of late interventions and progression to chronic limb threatening ischemia","volume":"77","author":"Sorber","year":"2023","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib76","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jvs.2021.02.045","article-title":"Revascularization of intermittent claudicants leads to more chronic limb-threatening ischemia and higher amputation rates","volume":"74","author":"Madabhushi","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib77","doi-asserted-by":"crossref","first-page":"e1032","DOI":"10.5435\/JAAOS-D-20-00556","article-title":"Shared decision-making in orthopaedic surgery","volume":"28","author":"Wilson","year":"2020","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib78","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1177\/0272989X18801308","article-title":"Informed, patient-centered decisions associated with better health outcomes in orthopedics: prospective cohort study","volume":"38","author":"Sepucha","year":"2018","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jvs.2025.04.041_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.ocarto.2022.100286","article-title":"An online individualised patient decision aid improves the quality of decisions in patients considering total knee arthroplasty in routine care: a randomized controlled trial","volume":"4","author":"Bansback","year":"2022","journal-title":"Osteoarthr Cartil open"},{"key":"10.1016\/j.jvs.2025.04.041_bib80","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.jvs.2018.06.193","article-title":"Major adverse limb events and major adverse cardiac events after contemporary lower extremity bypass and infrainguinal endovascular intervention in patients with claudication","volume":"68","author":"Fashandi","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib81","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jvs.2014.03.254","article-title":"C-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularization","volume":"60","author":"Stone","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib82","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12933-020-01072-x","article-title":"Influence of preprocedural glycemic control on clinical outcomes of endovascular therapy in diabetic patients with lower extremity artery disease: an analysis from a Korean multicenter retrospective registry cohort","volume":"19","author":"Cha","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jvs.2025.04.041_bib83","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1583\/13-4625R.1","article-title":"German multicenter real-world registry of stenting for superficial femoral artery disease: clinical results and predictive factors for revascularization","volume":"21","author":"Krankenberg","year":"2014","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvs.2025.04.041_bib84","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1078-5884(98)80048-8","article-title":"Vascular morbidity and mortality during long-term follow-up in claudicants selected for peripheral bypass surgery","volume":"16","author":"Dawson","year":"1998","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib85","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jfma.2019.10.011","article-title":"Contemporary cardiovascular outcomes in Taiwanese patients undergoing endovascular therapy for symptomatic lower extremity peripheral arterial disease","volume":"119","author":"Huang","year":"2020","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jvs.2025.04.041_bib86","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1583\/13-4618R.1","article-title":"Five-year prognosis after endovascular therapy in claudicant patients with iliofemoral artery disease","volume":"21","author":"Miura","year":"2014","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvs.2025.04.041_bib87","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jvs.2011.10.128","article-title":"Results for primary bypass versus primary angioplasty\/stent for intermittent claudication due to superficial femoral artery occlusive disease","volume":"55","author":"Siracuse","year":"2012","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib88","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1253\/circj.CJ-10-0077","article-title":"Long-term clinical outcome after endovascular treatment in patients with intermittent claudication due to iliofemoral artery disease","volume":"74","author":"Soga","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.jvs.2025.04.041_bib89","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.avsg.2019.08.073","article-title":"Factors associated with amputation after peripheral vascular intervention for intermittent claudication","volume":"62","author":"Axley","year":"2020","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib90","doi-asserted-by":"crossref","DOI":"10.1177\/2042018820960294","article-title":"Worse cardiovascular prognosis after endovascular surgery for intermittent claudication caused by infrainguinal atherosclerotic disease in patients with diabetes","volume":"11","author":"Dakhel","year":"2020","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.jvs.2025.04.041_bib91","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1177\/1526602820931477","article-title":"Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort","volume":"27","author":"Torsello","year":"2020","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvs.2025.04.041_bib92","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1067\/mva.2003.148","article-title":"Infrainguinal revascularization because of claudication: total long-term outcome of endovascular and surgical treatment","volume":"37","author":"J\u00e4ms\u00e9n","year":"2003","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib93","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.avsg.2020.08.097","article-title":"Prevalence and outcomes of endovascular infrapopliteal interventions for intermittent claudication","volume":"70","author":"Mullins","year":"2021","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib94","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/0003319711414866","article-title":"Clinical outcomes after endovascular treatment of superficial femoral disease in patients with disabling claudication and critical limb ischemia: midterm analysis","volume":"63","author":"Misselt","year":"2012","journal-title":"Angiology"},{"key":"10.1016\/j.jvs.2025.04.041_bib95","first-page":"1055","article-title":"Percutaneous revascularization of long femoral artery lesions for claudication: patency over 2.5 years and impact of systematic surveillance","volume":"77","author":"Connors","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2025.04.041_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1583\/11-3627.1","article-title":"Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial","volume":"19","author":"Laird","year":"2012","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvs.2025.04.041_bib97","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejvs.2007.02.009","article-title":"Association of circulating transforming growth factor beta, tumor necrosis factor alpha and basic fibroblast growth factor with restenosis after transluminal angioplasty","volume":"34","author":"Wildgruber","year":"2007","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib98","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2025.04.041_bib99","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1583\/05-1704.1","article-title":"Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial","volume":"13","author":"Duda","year":"2006","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvs.2025.04.041_bib100","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2012.04.035","article-title":"Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial","volume":"60","author":"Rastan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2025.04.041_bib101","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.jvs.2009.09.044","article-title":"Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia","volume":"50","author":"Conte","year":"2009","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib102","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jacc.2014.12.036","article-title":"Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from peripheral academic research consortium (PARC)","volume":"65","author":"Patel","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2025.04.041_bib103","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jvs.2016.03.420","article-title":"Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease","volume":"64","author":"Stoner","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib104","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.009584","article-title":"Contemporary review of antithrombotic therapy in peripheral artery disease","volume":"13","author":"Hess","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2025.04.041_bib105","doi-asserted-by":"crossref","first-page":"3d","DOI":"10.1016\/S0002-9149(01)01671-X","article-title":"Intermittent claudication: magnitude of the problem, patient evaluation, and therapeutic strategies","volume":"87","author":"Schmieder","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jvs.2025.04.041_bib106","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jvs.2022.06.023","article-title":"Focus group study of factors relevant to treatment decisions and experiences among patients with symptomatic peripheral artery disease","volume":"76","author":"Corriere","year":"2022","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib107","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.avsg.2022.05.036","article-title":"Female sex is associated with more reinterventions after endovascular and open interventions for intermittent claudication","volume":"86","author":"Levin","year":"2022","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib108","article-title":"Angioplasty versus stenting for iliac artery lesions","volume":"12","author":"Jongsma","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvs.2025.04.041_bib109","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0140-6736(97)09508-1","article-title":"Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group","volume":"351","author":"Tetteroo","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2025.04.041_bib110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1148\/radiology.204.1.9205227","article-title":"Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease","volume":"204","author":"Bosch","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.jvs.2025.04.041_bib111","article-title":"Angioplasty versus bare metal stenting for superficial femoral artery lesions","volume":"2014","author":"Chowdhury","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvs.2025.04.041_bib112","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/eurheartj\/ehac722","article-title":"Endovascular revascularization strategies for aortoiliac and femoropopliteal artery disease: a meta-analysis","volume":"44","author":"Koeckerling","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2025.04.041_bib113","article-title":"Atherectomy for peripheral arterial disease","volume":"9","author":"Wardle","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvs.2025.04.041_bib114","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejvs.2024.08.002","article-title":"Systematic review and network meta-analysis of vessel preparation techniques with plain balloon angioplasty, atherectomy, or intravascular lithotripsy before application of a drug coated balloon to treat atherosclerotic femoropopliteal disease","volume":"69","author":"Yiu","year":"2025","journal-title":"Eur J Vasc Endovascular Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib115","doi-asserted-by":"crossref","first-page":"643","DOI":"10.5551\/jat.57927","article-title":"Effect of target lesion revascularization on restenosis lesions of the superficial femoral artery without recurred symptoms after endovascular therapy","volume":"28","author":"Utsunomiya","year":"2021","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jvs.2025.04.041_bib116","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jvs.2011.08.010","article-title":"The natural history of duplex-detected stenosis after femoropopliteal endovascular therapy suggests questionable clinical utility of routine duplex surveillance","volume":"55","author":"Bui","year":"2012","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib117","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM199202063260605","article-title":"Mortality over a period of 10 years in patients with peripheral arterial disease","volume":"326","author":"Criqui","year":"1992","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jvs.2025.04.041_bib118","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.121.011320","article-title":"Patient-reported outcome measures in symptomatic, non-limb-threatening peripheral artery disease: a state-of-the-art review","volume":"15","author":"Rymer","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2025.04.041_bib119","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jvs.2020.10.090","article-title":"Intermittent claudication treatment patterns in the commercially insured non-Medicare population","volume":"74","author":"Siracuse","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib120","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jvs.2022.08.033","article-title":"Practice patterns surrounding the use of tibial interventions for claudication in the Medicare population","volume":"77","author":"Bose","year":"2023","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib121","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jvs.2022.02.034","article-title":"Index atherectomy peripheral vascular interventions performed for claudication are associated with more reinterventions than nonatherectomy interventions","volume":"76","author":"Kawaji","year":"2022","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib122","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jvs.2023.04.032","article-title":"Market competition influences practice patterns in management of patients with intermittent claudication in the vascular quality initiative","volume":"78","author":"Weaver","year":"2023","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib123","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.jvs.2020.10.067","article-title":"Endovascular interventions for claudication do not meet minimum standards for the Society for Vascular Surgery efficacy guidelines","volume":"73","author":"Bath","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib124","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejvs.2024.06.017","article-title":"Infrapopliteal peripheral vascular interventions for claudication are performed frequetly in the USA and are associated with poor long-term outcomes","volume":"69","author":"Bose","year":"2025","journal-title":"Eur J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib125","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000006368","article-title":"Infrapopliteal endovascular interventions for claudication are associated with poor long-term outcomes in Medicare-matched registry patients","author":"Bose","year":"2024","journal-title":"Ann Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib126","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jvs.2020.06.118","article-title":"Tibial bypass in patients with intermittent claudication is associated with poor outcomes","volume":"73","author":"Levin","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib127","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jvs.2022.04.012","article-title":"Society for Vascular Surgery appropriate use criteria for management of intermittent claudication","volume":"76","author":"Woo","year":"2022","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib128","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jvs.2019.05.034","article-title":"Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries","volume":"71","author":"Mohapatra","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib129","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jvs.2025.04.041_bib130","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1161\/CIRCULATIONAHA.119.044697","article-title":"Mortality and paclitaxel-coated devices: an individual patient data meta-analysis","volume":"141","author":"Rocha-Singh","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2025.04.041_bib131","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1056\/NEJMoa2005206","article-title":"Mortality with paclitaxel-coated devices in peripheral artery disease","volume":"383","author":"Nordanstig","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2025.04.041_bib132","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jamacardio.2019.0325","article-title":"Association of survival with femoropopliteal artery revascularization with drug-coated devices","volume":"4","author":"Secemsky","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jvs.2025.04.041_bib133","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008528","article-title":"Mortality after paclitaxel coated balloon angioplasty and stenting of superficial femoral and popliteal artery in the vascular quality initiative","volume":"13","author":"Bertges","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2025.04.041_bib134","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1016\/j.jcin.2021.08.058","article-title":"Vascular quality initiative surveillance of femoropopliteal artery paclitaxel devices","volume":"14","author":"Bertges","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2025.04.041_bib135","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejvs.2022.08.014","article-title":"Editor's Choice - real world study of mortality after the use of paclitaxel coated devices in peripheral vascular intervention","volume":"65","author":"Mao","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib137","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2025.04.041_bib138","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","article-title":"Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA","volume":"66","author":"Laird","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2025.04.041_bib139","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.117.028893","article-title":"Stellarex drug-coated balloon for treatment of femoropopliteal disease: twelve-month outcomes from the randomized ILLUMENATE Pivotal and pharmacokinetic studies","volume":"136","author":"Krishnan","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2025.04.041_bib140","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jvs.2016.10.089","article-title":"Paclitaxel-coated balloon reduces target lesion revascularization compared with standard balloon angioplasty","volume":"65","author":"Candy","year":"2017","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib141","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCINTERVENTIONS.111.962324","article-title":"Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results","volume":"4","author":"Dake","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2025.04.041_bib142","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(18)32262-1","article-title":"A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial","volume":"392","author":"Gray","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2025.04.041_bib143","article-title":"Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs","volume":"2016","author":"Kayssi","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvs.2025.04.041_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.avsg.2022.04.039","article-title":"Systematic review and meta-analysis of the outcomes of drug-eluting stent versus drug-coated balloon angioplasty for lower extremity peripheral artery diseases","volume":"85","author":"Wang","year":"2022","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2025.04.041_bib145","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/eurheartj\/ehn514","article-title":"Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials","volume":"30","author":"Kasapis","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2025.04.041_bib146","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1161\/CIRCULATIONAHA.122.059606","article-title":"Efficacy of a drug-eluting stent versus bare metal stents for symptomatic femoropopliteal peripheral artery disease: primary results of the EMINENT randomized trial","volume":"146","author":"Gou\u00ebffic","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2025.04.041_bib147","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa051303","article-title":"Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery","volume":"354","author":"Schillinger","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2025.04.041_bib148","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/CIRCINTERVENTIONS.109.903468","article-title":"Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial","volume":"3","author":"Laird","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2025.04.041_bib149","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2025.04.041_bib150","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891","article-title":"Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial","volume":"11","author":"Schneider","year":"2018","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521425010031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521425010031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:34:54Z","timestamp":1762310094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521425010031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":146,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0741521425010031"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2025.04.041","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Society for Vascular Surgery Clinical Practice Guideline on the management of intermittent claudication: Focused update","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2025.04.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2024.12.135","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Society for Vascular Surgery. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}